Familial Mediterranean Fever Clinical Trial
Official title:
The Movement Imagery Ability in Patients With Familial Mediterranean Fever
Verified date | August 2022 |
Source | Medipol University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Motor imagery is the mental representation of movement without any doing body movement. A main function of imagery is to aid the self-regulation of thoughts, feelings, and behaviours. Studies have shown to be more effective for individuals displaying a higher level of imagery ability when using imagery to improve motor and motivational outcomes, including self-efficacy. The aim of this study is to measure the movement imagery ability in patients with Familial Mediterranean Fever and compare it with healthy individuals.
Status | Completed |
Enrollment | 60 |
Est. completion date | February 18, 2021 |
Est. primary completion date | February 13, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - having had at least one attack last year - co-operated individuals Exclusion Criteria: - patients with a neurological disorder, - diagnosed with cancer, - cognitive impairment, - having a primary pathology of the musculoskeletal system, - having previous imagery practice, - having an additional rheumatic disease |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul University, Cerrahpasa Medical Faculty, Department of Rheumatology | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Medipol University | Istanbul University-Cerrahpasa |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Movement Imagery Questionnaire-3 (MIQ-3) | It is a questionnaire containing 12 items to evaluate the visual imagination skills of the individual. It evaluates internal visual imagery, external visual imagery, and kinesthetic imagery. For each item, first of all, individuals read the description of the movement, and then it is desired to perform the movement physically and after that, the same movement is requested. Individuals evaluate the degree of imagination on a 7-point Likert-type scale ranging from 1 (very difficult to see/feel) to 7 (very easy to see/feel). The motion visualization questionnaire has good psychometric properties, internal reliability, and estimated validity. | Baseline | |
Secondary | McGill Melzack Pain Questionnaire (MPQ) | MPQ consists of 78 descriptors grouped into four categories: sensory, affective, evaluative, and miscellaneous. These four categories were grouped into 20 subclasses each made up of 2 to 6 words according to pain intensity. Patients were asked to choose the pain descriptors according to the type of pain they felt during the attack episodes. Patients were instructed to choose one of the words that best described their type of pain experience. Changing of pain with time was assessed. Pain right now, pain at its worst and pain at its least was evaluated. Pain exacerbating or relieving factors were recorded. | Baseline | |
Secondary | Pain Catastrophizing Scale | Pain Catastrophizing Scale identifies catastrophic thoughts or feelings and ineffective coping strategies of patients. PCS is a Likert-type self-assessment scale consisting of thirteen items. Each item is evaluated between 0 and 4 points. The total score ranges from 0 to 52. Includes rumination, magnification, and helplessness subscales. High scores indicate that the level of disaster is high. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00658060 -
Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
|
N/A | |
Withdrawn |
NCT05448391 -
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
|
Phase 2 | |
Recruiting |
NCT05190991 -
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
|
Phase 2 | |
Completed |
NCT00094900 -
Interleukin-1 Trap to Treat Autoinflammatory Diseases
|
Phase 2 | |
Not yet recruiting |
NCT06033339 -
Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology
|
N/A | |
Completed |
NCT01705756 -
Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
|
Phase 3 | |
Recruiting |
NCT06338891 -
Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
|
||
Recruiting |
NCT05596643 -
Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever
|
||
Enrolling by invitation |
NCT02175589 -
Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
|
Phase 2 | |
Completed |
NCT05177120 -
Central Sensitization in Familial Mediterranean Fever (FMF)
|
||
Active, not recruiting |
NCT06257342 -
Physical Abilities of Teenagers With Familial Mediterranean Fever
|
||
Recruiting |
NCT04478409 -
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
|
||
Recruiting |
NCT06034795 -
Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever
|
||
Terminated |
NCT01059279 -
Heat Intolerance in the Group of FMF Patients
|
||
Enrolling by invitation |
NCT04724993 -
Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever
|
N/A | |
Completed |
NCT03747315 -
A Diagnostic Test for Familial Mediterranean Fever
|
||
Completed |
NCT01075906 -
Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
|
Phase 1 | |
Completed |
NCT00582907 -
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
|
Phase 2 | |
Withdrawn |
NCT00323440 -
Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
|
N/A | |
Not yet recruiting |
NCT05488561 -
Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings
|
N/A |